The HSIB was notified of a patient who died following an overdose of propranolol.
HSIB has launched an investigation regarding the potential under-recognised risk of the harm that can be caused by the use of propranolol.
The investigation will focus on awareness of the toxicity of propranolol, the speed of ambulance response to overdose calls, and the treatment of patients who have overdosed.
Contact us to receive updates
If you would like information about a particular investigation please let us knowContact us to receive updates